A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
Academic Article
Publication Date:
2011
Iris type:
1.1 Articolo in rivista
List of contributors:
Novotna, A; Mares, J; Ratcliffe, S; Novakova, I; Vachova, M; Zapletalova, O; Gasperini, C; Pozzilli, C; Cefaro, L; Comi, Giancarlo; Rossi, P; Ambler, Z; Stelmasiask, Z; Erdmann, A; Montalban, X; Klimek, A; Davies, P; Sativex Spasticity Study, Group
Published in: